RXDX Annual SG&A
$39.74 M
+$11.23 M+39.41%
31 December 2022
Summary:
As of January 22, 2025, RXDX annual selling, general & administrative expenses is $39.74 million, with the most recent change of +$11.23 million (+39.41%) on December 31, 2022. During the last 3 years, it has risen by +$33.61 million (+548.48%).RXDX Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RXDX Quarterly SG&A
$13.39 M
+$1.35 M+11.22%
31 March 2023
Summary:
As of January 22, 2025, RXDX quarterly selling, general & administrative expenses is $13.39 million, with the most recent change of +$1.35 million (+11.22%) on March 31, 2023. Over the past year, it has increased by +$5.31 million (+65.64%).RXDX Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RXDX TTM SG&A
-$1.25 B
-$150.56 M-13.69%
31 March 2023
Summary:
As of January 22, 2025, RXDX TTM selling, general & administrative expenses is -$1.25 billion, with the most recent change of -$150.56 million (-13.69%) on March 31, 2023. Over the past year, it has dropped by -$1.28 billion (-4086.37%).RXDX TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RXDX Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +39.4% | +65.6% | -4086.4% |
| 3 y3 years | +548.5% | +461.0% | -10000.0% |
| 5 y5 years | +548.5% | +461.0% | -10000.0% |
RXDX Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | at high | at high | -2877.3% |
Prometheus Biosciences Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | $13.39 M(+11.2%) | $45.02 M(+13.4%) |
| Dec 2022 | $39.74 M(+39.4%) | $12.04 M(+17.2%) | $39.72 M(+13.2%) |
| Sept 2022 | - | $10.27 M(+10.2%) | $35.09 M(+0.1%) |
| June 2022 | - | $9.32 M(+15.3%) | $35.07 M(+11.8%) |
| Mar 2022 | - | $8.09 M(+9.0%) | $31.37 M(+10.0%) |
| Dec 2021 | $28.50 M | $7.42 M(-27.6%) | $28.50 M(+14.9%) |
| Sept 2021 | - | $10.25 M(+82.4%) | $24.81 M(+39.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2021 | - | $5.62 M(+7.6%) | $17.73 M(+27.3%) |
| Mar 2021 | - | $5.22 M(+40.4%) | $13.92 M(+25.6%) |
| Dec 2020 | $11.09 M(+81.0%) | $3.72 M(+17.2%) | $11.09 M(+50.5%) |
| Sept 2020 | - | $3.17 M(+75.3%) | $7.37 M(+75.6%) |
| June 2020 | - | $1.81 M(-24.2%) | $4.20 M(+75.8%) |
| Mar 2020 | - | $2.39 M | $2.39 M |
| Dec 2019 | $6.13 M | - | - |
FAQ
- What is Prometheus Biosciences annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Prometheus Biosciences?
- What is Prometheus Biosciences annual SG&A year-on-year change?
- What is Prometheus Biosciences quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Prometheus Biosciences?
- What is Prometheus Biosciences quarterly SG&A year-on-year change?
- What is Prometheus Biosciences TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Prometheus Biosciences?
- What is Prometheus Biosciences TTM SG&A year-on-year change?
What is Prometheus Biosciences annual selling, general & administrative expenses?
The current annual SG&A of RXDX is $39.74 M
What is the all time high annual SG&A for Prometheus Biosciences?
Prometheus Biosciences all-time high annual selling, general & administrative expenses is $39.74 M
What is Prometheus Biosciences annual SG&A year-on-year change?
Over the past year, RXDX annual selling, general & administrative expenses has changed by +$11.23 M (+39.41%)
What is Prometheus Biosciences quarterly selling, general & administrative expenses?
The current quarterly SG&A of RXDX is $13.39 M
What is the all time high quarterly SG&A for Prometheus Biosciences?
Prometheus Biosciences all-time high quarterly selling, general & administrative expenses is $13.39 M
What is Prometheus Biosciences quarterly SG&A year-on-year change?
Over the past year, RXDX quarterly selling, general & administrative expenses has changed by +$5.31 M (+65.64%)
What is Prometheus Biosciences TTM selling, general & administrative expenses?
The current TTM SG&A of RXDX is -$1.25 B
What is the all time high TTM SG&A for Prometheus Biosciences?
Prometheus Biosciences all-time high TTM selling, general & administrative expenses is $45.02 M
What is Prometheus Biosciences TTM SG&A year-on-year change?
Over the past year, RXDX TTM selling, general & administrative expenses has changed by -$1.28 B (-4086.37%)